Patents by Inventor Sanjeev G. Shroff

Sanjeev G. Shroff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING HEART FAILURE
    Publication number: 20240342248
    Abstract: The present invention includes methods, systems, uses, and means for the delivery of one or more anti-fibrotic agents into the pericardial space for the treatment and prevention of heart failure (HF).
    Type: Application
    Filed: January 12, 2024
    Publication date: October 17, 2024
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: David Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles McTiernan
  • USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
    Publication number: 20220289809
    Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
    Type: Application
    Filed: November 5, 2021
    Publication date: September 15, 2022
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: David S. Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles F. McTiernan
  • METHOD OF TREATING HEART FAILURE
    Publication number: 20210275642
    Abstract: The present invention includes methods, systems, uses, and means for the delivery of one or more anti-fibrotic agents into the pericardial space for the treatment and prevention of heart failure (HF).
    Type: Application
    Filed: December 17, 2020
    Publication date: September 9, 2021
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: David Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles McTiernan
  • USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
    Publication number: 20200087371
    Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
    Type: Application
    Filed: July 11, 2019
    Publication date: March 19, 2020
    Inventors: David S. Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles F. McTiernan
  • USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
    Publication number: 20170342120
    Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
    Type: Application
    Filed: April 7, 2017
    Publication date: November 30, 2017
    Inventors: David S. Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles F. McTiernan
  • METHOD OF TREATING HEART FAILURE
    Publication number: 20170182128
    Abstract: The present invention includes methods, systems, uses, and means for the delivery of one or more anti-fibrotic agents into the pericardial space for the treatment and prevention of heart failure (HF).
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: David Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles McTiernan
  • USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
    Publication number: 20150232526
    Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
    Type: Application
    Filed: October 10, 2013
    Publication date: August 20, 2015
    Applicant: University of Pittsburgh-Of the Commonwealth System of Higher Education
    Inventors: David S. SCHWARTZMAN, Sanjeev G. SHROFF, Guy SALAMA, Charles F. MCTIERNAN
  • USE OF RELAXIN TO INCREASE ARTERIAL COMPLIANCE
    Publication number: 20140057832
    Abstract: The present invention provides methods for increasing arterial compliance. The methods generally involve administering to an individual in need thereof an effective amount of relaxin. The present invention further provides methods of increasing arterial compliance in individuals who have Type 1 or Type 2 diabetes. The present invention further provides methods of increasing arterial compliance in perimenopausal, menopausal, and post-menopausal women. The present invention further provides methods of increasing arterial compliance in individuals who have or who are at risk of developing age-associated arterial stiffness.
    Type: Application
    Filed: November 5, 2013
    Publication date: February 27, 2014
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Kirk P. Conrad, Sanjeev G. Shroff
  • Use of relaxin to increase arterial compliance
    Patent number: 8602998
    Abstract: The present invention provides methods for increasing arterial compliance. The methods generally involve administering to an individual in need thereof an effective amount of relaxin. The present invention further provides methods of increasing arterial compliance in individuals who have Type 1 or Type 2 diabetes. The present invention further provides methods of increasing arterial compliance in perimenopausal, menopausal, and post-menopausal women. The present invention further provides methods of increasing arterial compliance in individuals who have or who are at risk of developing age-associated arterial stiffness.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: December 10, 2013
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Kirk P Conrad, Sanjeev G Shroff
  • USE OF RELAXIN TO INCREASE ARTERIAL COMPLIANCE
    Publication number: 20110137291
    Abstract: The present invention provides methods for increasing arterial compliance. The methods generally involve administering to an individual in need thereof an effective amount of relaxin. The present invention further provides methods of increasing arterial compliance in individuals who have Type 1 or Type 2 diabetes. The present invention further provides methods of increasing arterial compliance in perimenopausal, menopausal, and post-menopausal women. The present invention further provides methods of increasing arterial compliance in individuals who have or who are at risk of developing age-associated arterial stiffness.
    Type: Application
    Filed: January 6, 2011
    Publication date: June 9, 2011
    Inventors: Kirk P. CONRAD, Sanjeev G. Shroff
  • Use of relaxin to increase arterial compliance
    Patent number: 7878978
    Abstract: The present invention provides methods for increasing arterial compliance. The methods generally involve administering to an individual in need thereof an effective amount of relaxin. The present invention further provides methods of increasing arterial compliance in individuals who have Type 1 or Type 2 diabetes. The present invention further provides methods of increasing arterial compliance in perimenopausal, menopausal, and post-menopausal women. The present invention further provides methods of increasing arterial compliance in individuals who have or who are at risk of developing age-associated arterial stiffness.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: February 1, 2011
    Assignee: University of Pittsburgh- Of The Commonwealth System of Higher Education
    Inventors: Kirk P. Conrad, Sanjeev G. Shroff